M/25/075 – Aspire Pharma/Caragen
Transaction details
The proposed acquisition by Aspire Pharma Limited, which is ultimately controlled by funds managed by H.I.G. Capital LLC of sole control of Caragen Limited, has been notified to the Competition and Consumer Protection Commission.
| Notification date | Decision date |
|---|---|
| Tuesday November 11, 2025 | |
| Parties Involved | Business activities |
|---|---|
| Aspire Pharma Limited | Aspire Pharma Limited develops, licenses and sells a range of pharmaceutical products. Aspire Pharma Limited is incorporated in England and Wales. Aspire Pharma Limited is ultimately controlled by H.I.G. Capital LLC. |
| H.I.G. Capital LLC | HIG Capital LLC is a global private equity and alternative assets investment firm specialising in providing both debt and equity capital to small and mid-sized companies. HIG Capital is incorporated in the State of Delaware, USA. |
| Caragen Limited | Caragen Limited sources, sells, markets and distributes pharmaceutical products and medical devices. Caragen Limited is incorporated in Ireland. |
| Economic sector | Media merger |
|---|---|
| Healthcare | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Monday, November 24, 2025 | |
| Current status: Active |
|---|
| Simplified Merger Notification |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Iseult O'Kelly | iseultokelly@ccpc.ie |
Media enquiries: communications@ccpc.ie
Haven’t found what you’re looking for?
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555